| 0 (0%) | 12-26 20:18 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 105.97 | 1-year : | 123.77 |
| Resists | First : | 90.73 | Second : | 105.97 |
| Pivot price | 89.94  |
|||
| Supports | First : | 88.02 | Second : | 86.36 |
| MAs | MA(5) : | 90.22 |
MA(20) : | 89.87 |
| MA(100) : | 87.91 |
MA(250) : | 0 | |
| MACD | MACD : | 0.3  |
Signal : | 0.3 |
| %K %D | K(14,3) : | 67.9 |
D(3) : | 71.2 |
| RSI | RSI(14): 55.8 |
|||
| 52-week | High : | 90.73 | Low : | 68.44 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ AOA ] has closed below upper band by 33.8%. Bollinger Bands are 40.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 90.54 - 90.99 | 90.99 - 91.37 |
| Low: | 89.01 - 89.5 | 89.5 - 89.9 |
| Close: | 89.48 - 90.25 | 90.25 - 90.88 |
Fri, 26 Dec 2025
AOA vs. ABIM: Real world effects on physicians - Medical Economics
Wed, 24 Dec 2025
AOA vs. ABIM: Introducing the lawsuit - Medical Economics
Mon, 22 Dec 2025
AOA vs. ABIM: Describing the growth of osteopathic medicine - Medical Economics
Sat, 06 Dec 2025
AOA responds to removal of CDC vaccine committee members - American Osteopathic Association
Wed, 03 Dec 2025
AOA files lawsuit to protect fair opportunities for physicians and residents - American Osteopathic Association
Fri, 21 Nov 2025
American Osteopathic Association statement on CDC website changes regarding autism and vaccines - American Osteopathic Association
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|